Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Translating the promise of 5HT4 receptor agonists for the treatment of depression.

Journal article

Murphy SE. et al, (2021), Psychol Med, 51, 1111 - 1120

Longitudinal DNA methylation changes associated with improvement of psychotic symptoms during clozapine treatment

Conference paper

Gillespie A. et al, (2020), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 31, S13 - S14

Health care and mental wellbeing in the transgender and gender-diverse Chinese population.

Journal article

Zhu X. et al, (2019), Lancet Diabetes Endocrinol, 7, 339 - 341

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA

Journal article

Sendt K-V. et al, (2018), Schizophrenia bulletin, 44, S382 - S382

SU116. Longitudinal Epigenetic Analysis of Clozapine Use in Treatment-Resistant Schizophrenia

Journal article

Gillespie A. et al, (2017), Schizophrenia bulletin, 43, S203 - S203